NCT00590954 2020-10-19
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
5 trialsNCT00422656 2017-12-26
Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00053924 2015-07-23
Perifosine in Treating Patients With Advanced Pancreatic Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00054145 2015-07-23
Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00873457 2013-05-27
Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Duke University
Phase 2 Completed